- Home
- ALCO vs IPHA Comparison
ALCO vs IPHA Comparison
Compare ALCO & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCO
- IPHA
- Stock Information
- Founded
- ALCO 1960
- IPHA 1999
- Country
- ALCO United States
- IPHA France
- Employees
- ALCO N/A
- IPHA N/A
- Industry
- ALCO
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- ALCO
- IPHA Health Care
- Exchange
- ALCO Nasdaq
- IPHA Nasdaq
- Market Cap
- ALCO 186.1M
- IPHA 148.3M
- IPO Year
- ALCO N/A
- IPHA 2019
- Fundamental
- Price
- ALCO $29.65
- IPHA $1.79
- Analyst Decision
- ALCO
- IPHA Strong Buy
- Analyst Count
- ALCO 0
- IPHA 1
- Target Price
- ALCO N/A
- IPHA $11.50
- AVG Volume (30 Days)
- ALCO 93.3K
- IPHA 779.8K
- Earning Date
- ALCO 02-05-2025
- IPHA 09-12-2024
- Dividend Yield
- ALCO 0.69%
- IPHA N/A
- EPS Growth
- ALCO 279.17
- IPHA N/A
- EPS
- ALCO 0.91
- IPHA N/A
- Revenue
- ALCO $46,643,000.00
- IPHA $36,202,722.00
- Revenue This Year
- ALCO $91.35
- IPHA N/A
- Revenue Next Year
- ALCO N/A
- IPHA $101.65
- P/E Ratio
- ALCO $32.77
- IPHA N/A
- Revenue Growth
- ALCO 17.06
- IPHA N/A
- 52 Week Low
- ALCO $24.14
- IPHA $1.29
- 52 Week High
- ALCO $34.08
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- ALCO 61.95
- IPHA 45.92
- Support Level
- ALCO $28.58
- IPHA $1.64
- Resistance Level
- ALCO $34.08
- IPHA $1.87
- Average True Range (ATR)
- ALCO 1.21
- IPHA 0.12
- MACD
- ALCO 0.38
- IPHA -0.04
- Stochastic Oscillator
- ALCO 52.47
- IPHA 28.66
About ALCO Alico Inc.
Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.